Dublin, Nov. 24, 2017 (GLOBE NEWSWIRE) -- The "Generic Injectables Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2017-2022" report has been added to Research and Markets' offering. The global generic injectables market reached a value of more than US$ 43 Billion in 2016, exhibiting a CAGR of around 9% during 2009-2016. Owing to the advantages offered by generic injectables, governments in various countries are supporting their manufacture. Additionally, an increase in drug shortages, especially in the US, along with patent expiry of a number of blockbuster drugs, aging population and rising prevalence of chronic as well as lifestyle diseases represent some of the other factors driving the growth of the market. According to Generic Injectables Market: The report has segmented the market on the basis of therapeutic area as oncology, anaesthesia, anti-infectives, parenteral nutrition, cardiovascular and others. Currently, the oncology segment accounts for the majority of the total market share. Further, the report has segmented the market on the basis of distribution channels covering hospitals and retail pharmacy stores. Among these, hospitals account for the largest market share. On a regional-basis, the report covers North America, Europe, Asia, Latin America, and Middle East and Africa. North America represents the largest region, accounting for more than a half of the total global share. The report has also analysed the competitive landscape of the market with some of the key players being Hospira (Pfizer), Fresenius Kabi, Hikma, Sandoz (Novartis), Sagent, Sanofi and Baxter. Key Topics Covered: 1 Preface 2 Scope and Methodology 2.1 Objectives of the study 2.2 Stakeholders 2.3 Data Sources 2.3.1 Primary Sources 2.3.2 Secondary Sources 2.4 Market Estimation 2.4.1 Bottom-Up Approach 2.4.2 Top-Down Approach 2.5 Forecasting Methodology 3 Executive Summary 4 Introduction 4.1 Overview 4.2 Key Industry Trends 5 Global Generic Drug Market 5.1 Market Overview 5.2 Market Performance 5.3 Market Breakup by Region 5.4 Market Forecast 5.5 Major Players 6 Global Generic Drug Delivery Market 6.1 Oral 6.2 Injectables 6.3 Dermal/Topical 6.4 Inhalers 7 Global Generic Injectables Market 7.1 Market Overview 7.2 Market Performance 7.3 Market Breakup by Region 7.4 Market Breakup by Therapeutic Area 7.5 Market Breakup by Distribution Channel 7.6 Market Forecast 7.7 SWOT Analysis 7.7.1 Strengths 7.7.2 Weaknesses 7.7.3 Opportunities 7.7.4 Threats 7.8 Value Chain Analysis 7.9 Porter's Five Forces Analysis 7.9.1 Overview 7.9.2 Bargaining Power of Buyers 7.9.3 Bargaining Power of Suppliers 7.9.4 Degree of Competition 7.9.5 Threat of New Entrants 7.9.6 Threat of Substitutes 7.10 Key Market Drivers and Success Factors 8 Global Generic Injectables Market: Performance of Key Regions 8.1 North America 8.2 Europe 8.3 Asia 8.4 Latin America 8.5 Middle East and Africa 9 Market by Therapeutic Area 9.1 Oncology 9.2 Anaesthesia 9.3 Anti-infectives 9.4 Parenteral Nutrition 9.5 Cardiovascular 10 Market by Distribution Channel 10.1 Hospitals 10.2 Retail Pharmacy Stores 11 Global Generic Injectable Market: Competitive Landscape 11.1 Competitive Structure 11.2 Market Breakup by Key Players 12 Generic Injectable Manufacturing Process 12.1 Product Overview 12.2 Detailed Process Flow (Injectable) 12.3 Various Types of Unit Operations Involved 12.4 Mass Balance and Raw Material Requirements 13 Project Details, Requirements and Costs Involved 13.1 Land Requirements and Expenditures 13.2 Construction Requirements and Expenditures 13.3 Plant Machinery 13.4 Machinery Pictures 13.5 Raw Material Requirements and Expenditures 13.6 Packaging Requirements and Expenditures 13.7 Transportation Requirements and Expenditures 13.8 Utility Requirements and Expenditures 13.9 Manpower Requirements and Expenditures 13.10 Other Capital Investments 14 Loans and Financial Assistance 15 Project Economics 15.1 Capital Cost of the Project 15.2 Techno-Economic Parameters 15.3 Product Pricing and Margins Across Various Levels of the Supply Chain 15.4 Taxation and Depreciation 15.5 Income Projections 15.6 Expenditure Projections 15.7 Financial Analysis 15.8 Profit Analysis 16 Key Player Profiles For more information about this report visit https://www.researchandmarkets.com/research/r7nf8p/generic
CONTACT: Research and Markets Laura Wood, Senior Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 Related Topics: Infusions and Injectables
